Cargando…

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer

The role of immune checkpoints (ICPs) in both anti-HIV T cell exhaustion and HIV reservoir persistence, has suggested that an HIV cure therapeutic strategy could involve ICP blockade. We studied the impact of anti-PD-1 therapy on HIV reservoirs and anti-viral immune responses in people living with H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baron, Marine, Soulié, Cathia, Lavolé, Armelle, Assoumou, Lambert, Abbar, Baptiste, Fouquet, Baptiste, Rousseau, Alice, Veyri, Marianne, Samri, Assia, Makinson, Alain, Choquet, Sylvain, Mazières, Julien, Brosseau, Solenn, Autran, Brigitte, Costagliola, Dominique, Katlama, Christine, Cadranel, Jacques, Marcelin, Anne-Geneviève, Lambotte, Olivier, Spano, Jean-Philippe, Guihot, Amélie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946896/ https://www.ncbi.nlm.nih.gov/pubmed/35326466 http://dx.doi.org/10.3390/cells11061015

Ejemplares similares

Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy
por: Bertin, Lise, et al.
Publicado: (2021)

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
por: Hattab, Suhaib, et al.
Publicado: (2014)

Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
por: Sellem, Baptiste, et al.
Publicado: (2023)

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients
por: ABDI, Basma, et al.
Publicado: (2022)

Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area
por: Katlama, Christine, et al.
Publicado: (2022)

Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition
por: Palich, Romain, et al.
Publicado: (2021)

Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2012)

Vaccination contre le SARS-CoV-2 avant l’introduction d’un traitement par anti-CD20 chez les patients atteints de sclérose en plaques : une protection durable ?
por: Jeantin, Lina, et al.
Publicado: (2023)

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
por: Gazzano, Marianne, et al.
Publicado: (2022)

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc
por: Rodriguez, Christophe, et al.
Publicado: (2015)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

The HIV-1 Antisense Protein (ASP) induces CD8 T cell responses during chronic infection
por: Bet, Anne, et al.
Publicado: (2015)

Superior control of HIV-1 replication by CD8(+) T cells is reflected by their avidity, polyfunctionality, and clonal turnover
por: Almeida, Jorge R., et al.
Publicado: (2007)

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
por: Rouers, Angeline, et al.
Publicado: (2017)

Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study
por: Guezour, Nadia, et al.
Publicado: (2022)

CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic Epitope
por: Cardinaud, Sylvain, et al.
Publicado: (2011)

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study
por: Lanoy, E, et al.
Publicado: (2009)

Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children
por: Fofana, Djeneba B., et al.
Publicado: (2023)

Identification of natural killer markers associated with fatal outcome in COVID-19 patients
por: Tarantino, Nadine, et al.
Publicado: (2023)

Dynamics in HIV‐DNA levels over time in HIV controllers
por: Avettand‐Fenoel, Véronique, et al.
Publicado: (2019)

Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data
por: Houssaïni, Allal, et al.
Publicado: (2012)

Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

HIV controllers: state of the art
por: Lambotte, Olivier
Publicado: (2010)

Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
por: Vieillard, Vincent, et al.
Publicado: (2016)

Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
por: Martin-Blondel, Guillaume, et al.
Publicado: (2022)

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration
por: Boufassa, Faroudy, et al.
Publicado: (2014)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
por: Ghosn, J, et al.
Publicado: (2010)

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects
por: Gach, Johannes S., et al.
Publicado: (2016)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection
por: Guihot, Amélie, et al.
Publicado: (2022)

Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients
por: Nakid-Cordero, Cecilia, et al.
Publicado: (2019)

Conventional Dendritic Cells and Slan(+) Monocytes During HIV-2 Infection
por: Iannetta, Marco, et al.
Publicado: (2020)

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021)

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease
por: Sacre, Karim, et al.
Publicado: (2005)

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
por: Katlama, Christine, et al.
Publicado: (2009)

Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19
por: Burrel, Sonia, et al.
Publicado: (2021)

A Pilot Study of the Humoral Response Against the AntiSense Protein (ASP) in HIV-1-Infected Patients
por: Savoret, Juliette, et al.
Publicado: (2020)

HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication
por: Andre, Mickensone, et al.
Publicado: (2023)

Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure
por: Li, Shuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_71mg2f6961eh4hr2gcjsbcgthn